Asenapine
Active substance: asenapine
TABLET · ASENAPINE 5 mg/1
United StatesActive
Marketing holder: Alembic Pharmaceuticals Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
Composition
- ASENAPINE · 5 mg/1
Analogues by country
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c5-076b-73b4-a005-16c52ea5b47e;count=1 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-aa2e-76a9-8159-5e55ab7a34b7,01a1208d-3afe-78f9-819e-d066afad24c7,01a1208e-9c03-7889-9bf2-a8f7bfb81873,01a1208e-cc2c-71ff-b740-af5be8aed378,01a12090-1dff-7b63-a6dd-85ddcf8cefd0;count=24 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 62332-198
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBLINGUAL
Sources
- product · openFDA NDC · 62332-198 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 62332-198 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 62332-198 · Verified 2026-10-09 · open in source